OTR Acquisition Corp.
OTRAU
NASDAQ Capital Market9.55
USD
-1.99
- -
CIK
0001821318
ISIN
US67113Q2049
CUSIP
67113Q204
Return %
Stock
S&P500
1Y
- -
18.21
3Y
- -
64.38
5Y
-4.02
72.43
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 1395 Brickell Avenue Miami FL United States of America 33131
- IPO Date
- Oct 30, 2020
- CIK
- 0001821318
- Website
- otracquisition.com
- Similar Companies
- Business
- OTR Acquisition Corp. (OTRAU) operates as a blank check company, or special purpose acquisition company (SPAC), focused on effecting mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations with one or more unidentified businesses. Incorporated in 2020 and headquartered in Miami, Florida, the company holds no significant operations beyond pursuing and completing such transactions. In May 2022, OTR Acquisition Corp. completed a reverse merger with Comera Life Sciences Holdings, Inc., through which it was acquired, marking its primary strategic transaction and resulting in delisting from active trading as a standalone SPAC.
6 Stocks Halted In Wednesday's Session: Here's Why
Biologic Medicines-Focused Comera Life Sciences Turns To SPAC For NASDAQ Debut
U.S. IPO Weekly Recap: Breast Cancer Biotech Pops 158% In A 6-IPO Week
U.S. IPO Weekly Recap: Biotechs And SPACs Ride The Summer Wave In A 4 IPO Week